BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20849387)

  • 21. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
    Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
    Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
    Hall CP; Reynolds CP; Kang MH
    Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
    Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
    Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.
    Schmidt S; Rainer J; Ploner C; Presul E; Riml S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S45-55. PubMed ID: 15243581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells.
    Lu J; Quearry B; Harada H
    FEBS Lett; 2006 Jun; 580(14):3539-44. PubMed ID: 16730715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
    Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
    J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells.
    Planey SL; Abrams MT; Robertson NM; Litwack G
    Cancer Res; 2003 Jan; 63(1):172-8. PubMed ID: 12517795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals.
    von Gise A; Lorenz P; Wellbrock C; Hemmings B; Berberich-Siebelt F; Rapp UR; Troppmair J
    Mol Cell Biol; 2001 Apr; 21(7):2324-36. PubMed ID: 11259582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.
    McCubrey JA; Steelman LS; Abrams SL; Bertrand FE; Ludwig DE; Bäsecke J; Libra M; Stivala F; Milella M; Tafuri A; Lunghi P; Bonati A; Martelli AM
    Leukemia; 2008 Apr; 22(4):708-22. PubMed ID: 18337766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes.
    Smith LK; Cidlowski JA
    Prog Brain Res; 2010; 182():1-30. PubMed ID: 20541659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways.
    Webb MS; Miller AL; Howard TL; Johnson BH; Chumakov S; Fofanov Y; Nguyen-Vu T; Lin CY; Thompson EB
    Mol Cell Endocrinol; 2018 Aug; 471():118-130. PubMed ID: 29596968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
    Greenstein S; Ghias K; Krett NL; Rosen ST
    Clin Cancer Res; 2002 Jun; 8(6):1681-94. PubMed ID: 12060604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence-specific transcription factors during glucocorticoid-induced apoptosis in acute lymphoblastic leukemia cells.
    Hartmann BL; Geley S; Kofler R
    Wien Klin Wochenschr; 1999 May; 111(9):360-7. PubMed ID: 10407997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3.
    Delangre E; Liu J; Tolu S; Maouche K; Armanet M; Cattan P; Pommier G; Bailbé D; Movassat J
    Cell Death Dis; 2021 Dec; 12(12):1136. PubMed ID: 34876563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.